NHS National Framework for the supply of Generics Housekeeping / Supply Chain Resilience Products, commencing 1 June 2025
Details
- Buyer
- NHS England
- Supplier(s)
31 suppliers
- Accord UK Ltd
- Amarox Ltd
- Aspire Pharma Ltd
- B. BRAUN MEDICAL LIMITED
- Bowmed Ibisqus Ltd
- Dr Reddy's Laboratories (UK) Ltd
- DRUGSRUS LIMITED
- Ennogen HealthCare
- Farmak Pharmaceuticals
- FRESENIUS KABI LIMITED
- Grindeks Kalceks UK Ltd
- Hameln Pharma Ltd
- JCSH Pharma Ltd
- Kent Pharma Ltd
- Luye Pharma Ltd
- Macleods Pharma UK Limited
- Martindale Pharma
- Medreich Plc
- Mercury Pharmaceuticals Ltd
- Milpharm Ltd/aurobinbdo
- Morningside Pharmaceuticals Ltd
- Mylan
- Neon Healthcare Ltd
- Novumgen Limited
- Panpharma UK Ltd
- Pfizer Liimted
- Rosemont Pharmaceuticals Ltd
- Seacross Pharmaceuticals Ltd
- SVP Pharma Ltd
- Teva UK Ltd
- Wockhardt UK Limited
- Value
- £36
- Topic
- Pharmaceutical products
- Published
- 8 May 2025
- Source
- uk:find_a_tender
Tender description
Project title: NHS National Framework for the supply of Generics Housekeeping / Supply Chain Resilience Products, commencing 1 June 2025<br/><br/>Offer reference number: CM/PHG/24/5720<br/><br/>Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months. <br/><br/>Potential periods of call-offs under the framework agreement:<br/>CM/PHG/24/5720/01 – Orals (plus non-parenteral) Products<br/>CESW: (Midlands and Southwest): 1st June 2025 to 31st May 2027 (24 months)<br/>NWLN: (Northwest and London North): 1st June 2025 to 31st May 2027 (24 months)<br/>LSNE: (London South and Northeast): 1st June 2025 to 31st May 2027 (24 months)<br/><br/>CM/PHG/24/5720/02 – Hospital Only Products<br/>DCE (Midlands) & DSW (Southwest): 1st June 2025 to 31st May 2026 (12 months)<br/>DNW (Northwest) & DLN (London North): 1st June 2025 to 31st January 2027 (20 months)<br/>DLS (London South) & DNE (Northeast): 1st June 2025 to 31st May 2026 (12 months)<br/><br/>Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England Lot 1: CM/PHG/24/5720/01 – Orals (plus non-parenteral) Products CM/PHG/24/5720/01 – Orals (plus non-parenteral) Products<br/>CESW: (Midlands and Southwest): 01/06/2025 to 31/05/2027 (24 months) <br/>NWLN: (Northwest and London North): 01/06/2025 to 31/05/2027 (24 months)<br/>LSNE: (London South and Northeast): 01/06/2025 to 31/05/2027 (24 months) Additional information: Price is not the only award criterion and all criteria are stated in the procurement documents. Lot 2: CM/PHG/24/5720/02 – Hospital Only Products CM/PHG/24/5720/02 – Hospital Only Products<br/>DCE (Midlands) & DSW (Southwest): 01/06/2025 to 31/05/2026 (12 months), <br/>DNW (Northwest) & DLN (London North): 01/06/2025 to 31/01/2027 (20 months) <br/>DLS (London South) & DNE (Northeast): 01/06/2025 to 31/05/2026 (12 months)
Timeline
- Completed: Award date16 April 2025
- Completed: Award published8 May 2025Current notice
About the buyer
NHS England runs the NHS in England, and buys as a central healthcare organisation with its own team of procurement professionals. Every tender is advertised on Atamis, the NHS's single eCommercial system, and larger contracts appear on Find a Tender. Much of this procurement flows through framework agreements and the Crown Commercial Service. Clinical services are commissioned directly or through the Provider Selection Regime. Seven regional teams support the commissioning of healthcare services across the country. The central commercial function that develops procurement strategy for the whole NHS sits here.
UK health spending has nearly quadrupled to £241.8bn in 2024/25, £20bn up on the year before. £140.6bn of that went to procurement, the biggest sector of UK public spending and the fastest-growing.
Over the past 5 years, most of NHS England's contract awards have been in education and training, health and social work, and IT services.
Relevant CPV codes
- 33600000 · Pharmaceutical products
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-england.gov |
14 similar open tenders
See more open tenders related to NHS National Framework for the supply of Generics Housekeeping / Supply Chain Resilience Products, commencing 1 June 2025.
- Open tender
Generic Drugs - Injections/Infusions
- Open tender
IMP Manufacture, Labelling and Packaging DPS
- Open tender
CPH037 - Enhanced Services (Pharmacies)
Related topics
Topics related to NHS National Framework for the supply of Generics Housekeeping / Supply Chain Resilience Products, commencing 1 June 2025, ranked by notice volume.
- 44,608£7.6tn
Related buyers
Buyers similar to NHS England.
- 509£245.0m
- 429£15.3bn
- 426£117.3m
- 380£641.6m
- 320£18.9bn
- 298£3.1bn
- 295£1.7bn
- 269£1.2bn
- 153£987.8m
- 147£115.2m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
